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INTRODUCTION
Neonatal chronic lung disease (CLD) (1-3) is one of the
serious sequelae of very low birth weight infants. Inspite of
various therapies such as fluid restriction (4), corticosteroids
(5), vitamin A (6), low positive inspiratory pressure (PIP)
and permissive hypercapnea (7), high-frequency ventilation
(HFV) (8) and inhaled nitrogen oxide (9) have been and are
still being tried to prevent the development of neonatal CLD,
there is no specific treatment for CLD once it is established,
indicating the importance of early detection in decreasing
the incidence of neonatal CLD.
Many regression models have been developed to predict
the development of neonatal CLD (10-19), but some limita-
tions were present; 1) most of them were investigated prior
to the use of surfactant replacement or HFV, 2) logistic reg-
ression equations used were too difficult and highly compli-
cated for bedside application, and 3) the prospective popu-
lations for validation were different from retrospective pop-
ulations, suggesting problems in accuracy and reliability.
Therefore a simple, modern and appropriate-population-based
clinical method was needed to acquire information which
patients would be at risk of neonatal CLD in the future.
In our previous study, we found that PIP over birth weight
(PIP/kg) at 12 hr of age, mean airway pressure (MAP) over
birth weight (MAP/kg) and modified oxygenation index
[MAP/kg×a fractional inspired oxygen (FiO2)÷partial pres-
sure of oxygen in arterial blood (PaO2)] were significant risk
factors for the development of CLD than traditionally used
PIP, MAP and oxygenation index (20). We, therefore, hypoth-
esized that a scoring method using those modified respiratory
parameters would be able to better predict the development
of CLD than other methods using conventional respiratory
variables. 
The aims of this study were to develop a simple clinical
scoring method for predicting neonatal CLD using modified
respiratory variables, and to determine and compare the pre-
dictive values of our scoring system. 
MATERIALS AND METHODS
Of the 203 infants with birth weight <1,500 g admitted
to the neonatal intensive care unit (NICU) at Asan Medical
Center (Seoul, Korea) between January 1997 and December
1999 (period I), 197 infants were enrolled and their medical
records reviewed retrospectively. Patients with life-threaten-
ing congenital malformation (n=3) and incomplete medical
records (n=3) were excluded. Recorded data were divided
into 3 groups: maternal factors, neonatal factors and ventila-
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In our previous study, we have demonstrated that peak inspiratory pressure over
birth weight (PIP/kg) and mean airway pressure over birth weight (MAP/kg) were
more significant risk factors for the development of neonatal chronic lung disease
(CLD) than PIP and MAP. We aimed to develop a scoring method using the modi-
fied respiratory variables (SMUMRV) to predict CLD at early postnatal period. From
1997 to 1999, a retrospective review was performed for 197 infants <1,500 g for the
development of the SMUMRV based on statistical analysis. From 2000 to 2001, cal-
culated scores on day 4, 7 and 10 of life were obtained prospectively for 107 infants
<1,500 g. Predictive values and the area under the receiver operator characteristic
curve (AUC) were determined and compared with the result of the previous regres-
sion model. Gestational age, birth weight, 5 min Apgar score, PIP/kg at 12 hr of age,
fractional inspired oxygen (FiO2), MAP/kg, modified oxygenation index and ventila-
tory mode were selected as parameters of SMUMRV. No significant differences of
AUCs were found between the SMUMRV and the Yoder model. It is likely that our
scoring method provides reliable values for predicting the development of CLD in
very low birth weight infants. 
Key Words : Bronchopulmonary Dysplasia; Infant, Premature; Predictive Value of Tests; ROC Curve; Scoring
Method; Epidemiologic Research Design398 Y.D. Kim, A.-R. Kim, K.-S. Kim, et al.
tor-associated factors. Maternal factors include maternal age,
mode of delivery, duration of premature ruptured membrane,
antenatal corticosteroids, white blood cell (WBC) count in
amniotic fluid, placental pathology, maternal WBC count
and maternal serum C-reactive protein (CRP) level. Neona-
tal factors include birth weight, gestational age, small for
gestational age, sex, 1 min and 5 min Apgar score, patent
ductus arteriosus, respiratory distress syndrome (RDS), sur-
factant supplementation, amount of fluid administered within
3 days of life, blood WBC count, and serum level of CRP and
total immunoglobulin M. Ventilator-associated factors includ-
ed FiO2, PaO2, a partial pressure of carbon dioxide in arterial
blood (PaCO2), PIP/kg at 12 hr of age, MAP/kg and the modi-
fied oxygenation index. Those ventilator-associated factors
were recorded on day 4, 7 and 10 of life, respectively. 
All descriptive variables were categorized and scored with-
in the limits. A range of values was selected for each variable,
and points were initially awarded as -1, 0, 1, 2 and 3 for each
parameter based on the measured value. Those variables cat-
egorized were entered into logistic regression analysis. Cate-
gorized variables not independently significantly associated
with CLD were removed from the model. After its removal,
the logistic regression was repeated until only significantly
related variables remained. Based on the results of regression
analysis, gestational age, FiO2 and MAP/kg were selected.
Five variables including birth weight, 5 min Apgar score,
PIP/kg at 12 hr of age, modified oxygenation index and ven-
tilatory modality, based on our clinical experiences, were also
adopted for development of the scoring system. All of them
were statistically highly significant in univariate analysis. The
total score was determined by the subtotals of the parameters
in the scoring table. The primary outcome variable was CLD
diagnosed at 36 weeks of corrected age (CA). Using the total
score and outcome data, receiver operator characteristic (ROC)
curves were developed, and predictive values and area under
the ROC curve (AUC) were determined. We were unable to
use maternal factors in the development of our model since
data for many mothers were missing.
From January 2000 to August 2001 (period II), 107 infants
with birth weight <1,500 g admitted at the same center were
evaluated prospectively for cross-validation, utilizing the
results of the period I patients. Prospective data in period II
were collected to validate the usefulness of sensitivity, speci-
ficity, and predictive values obtained from the regression
model generated from retrospective data in period I. Calcu-
lated score on day 4, 7 and 10 of life and its true outcome
data were matched and plotted over ROC curve to obtain
their AUCs. The results of AUC in period II were compared
with those in period I.
After determination of an optimal regression model for
predicting CLD, other methods for predicting CLD were
compared with our model. Yoder et al. (12) developed res-
piratory failure score (Yoder model) for infants <32 weeks’
gestation for prediction of CLD in 1999. To our knowledge,
Yoder model was the first scoring method to predict the devel-
opment for premature infants. We evaluated the infants on
day 4, 7 and 10 days of life using the two published method.
Mechanical ventilation using modes of continuous positive
end-expiratory pressure (CPAP), intermittent mandatory
ventilation/synchronous intermittent mandatory ventilation
(IMV/SIMV), assisted/control (A/C) and HFV was initiated
based on clinical manifestations and results of blood gas analy-
sis. Indications for CPAP included frequent recurrent apnea,
chest retraction with or without grunting, and PaO2 <50
mmHg in 40% oxygen. Indications for mechanical ventila-
tion included CPAP failure, PaCO2 >50 mmHg in 60% oxy-
gen, and persistent respiratory acidosis (21). Nasal CPAP was
also regarded as a mode of CPAP. CLD was diagnosed if the
infants had prolonged oxygen requirements at 36 weeks of
CA (3). HFV was applied as rescue therapy during the study
periods and the MAP was adjusted to 2.0 cmH2O higher than
that of a conventional mode of ventilation (8, 22). Patients
without mechanical ventilation were given the lowest scores.
Chest radiographic findings within 10 days of age were ex-
cluded from the analysis because we found no significant asso-
ciation with the development of CLD.
Data were analyzed using SPSS 10.0 software (SPSS. Inc.,
Chicago, IL, U.S.A.). Categorical variables were compared by
using Fischer’s exact test or the chi-square test, and contin-
uous variables were compared by ANOVA, Kruskal-Wallis
test or Wilcoxon rank sum test. After selecting the signifi-
cant variables in the univariate analysis, they were entered
into the stepwise selection method to make a predictive logis-
tic model. Differences between ROC curves were compared
using MedCalc 7.2 software (MedCalc Software, Belgium).
The level of significance was set at p<0.05.
RESULTS
Of the 197 very low birth weight (VLBW) infants who
were recruited for retrospective study during period I, 164
(83.2%) were survived to 36 weeks of CA, 87 (44.2%) were
weighed ≤1,000 g, 123 (62.4%) were ≤28 weeks’ gesta-
tion, and 105 (53.3%) had been treated for RDS. Of the 107
VLBW infants during period II, 96 (89.7%) survived to 36
weeks of CA, 43 (40.2%) weighed ≤1,000 g, 53 (49.5%)
were ≤28 weeks’ gestation, and 51 (47.7%) had been treat-
ed for RDS. Mean gestational age and birth weight (±SD)
were 28.2±1.9 weeks and 1,043.3±262.6 g in period I,
and 28.5±1.9 weeks and 1,095.4±270.1 g in period II,
respectively. Table 1 demonstrates demographic data of the
study subjects enrolled for statistical analysis during each time
period. There were no significant differences except for the
5 min Apgar score in demographic data between the two
periods. The incidence of CLD at 36 weeks of CA was 18.6%
(30/161) in period I, and 9.4% (9/96) in period II, respectively
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Table 2 demonstrates the selected eight variables based on
the results of regression analysis and our clinical experience.
Each was given a value and entered into a scoring table on
day 4, 7 and 10 of life. According to the scoring table, total
scores were determined and matched with the primary out-
come, the incidence of CLD at 36 weeks of CA. 
A series of ROC curves was developed to compare the pre-
dictivity of each study period. Areas under the constructed
ROC curves on day 4, 7 and 10 of life were 0.76 (SEM, 0.05),
0.84 (SEM, 0.05) and 0.86 (SEM, 0.05) in period I, and 0.90
(SEM, 0.07), 0.91 (SEM, 0.07) and 0.94 (SEM, 0.05) in period
II. And then, we compared the AUCs of our model (SMUM-
RV) with those of Yoder model on our study subjects in peri-
od II. Fig. 1 shows the comparison of ROC curves and their
AUCs for each method tested. Areas under the ROC curves
of Yoder model and the p values of statistical results com-
pared with AUCs of SMUMRV were as follows; 0.92 (SEM,
0.06) on day 4 (p=0.73), 0.96 (SEM, 0.05) on day 7 (p=0.38),
and 0.95 (SEM, 0.05) on day 10 (p=0.85).
With the establishment of ROC curves, the cutoff values
showing the best equilibrium between sensitivity and speci-
ficity were 4 on day 4, 1 on day 7, and 1 on day 10 in period
I, and 11 on day 4, 10 on day 7, and 11 on day 10 in period
II. Table 3 demonstrates the sensitivity, specificity, positive
predictive value (PPV) and negative predictive value (NPV)
that were determined on day 4, 7 and 10 of life according to
the specific cut-off values in SMUMRV and Yoder’s model.
As a single value to predict risk for CLD, only the SMUM-
RV value >13 on day 10 of age reached 75% with sufficient
levels of sensitivity and specificity.
DISCUSSION
In our previous study (20), we found that PIP/kg, MAP/kg
were more significantly related to the development of CLD
rather than conventional PIP and MAP. These findings sug-
Period I (n=197) Period II (n=107) p value
Gestation (weeks) 28±22 9 ±2 0.17
Birth weight (g) 1,043±263 1,095±270 0.10
Male (%) 102 (51.8) 61 (57) 0.86
1 min Apgar score 4 (0-8) 5 (2-9) 0.33
5 min Apgar score 7 (1-9) 7 (2-10) 0.01
Cesarean section  95 (48.2) 62 (57.9) 0.19
Maternal age (yr) 30.6±4.1 30.8±4.3 0.71
RDS 105  (53.3) 51  (47.7) 0.15
IVH grade III-IV  12 (6.1) 4 (3.7) 0.16
ROP ≥stage 3  28/163 (17.2) 14 (13.1) 0.22
CLD at 36 weeks of CA 30/161 (18.6) 9/96 (9.4) 0.05
Death < 36 wks of CA 34/197 (17.3) 11/107 (10.3) 0.08
Table 1. Patient characteristics during each time period
Values are means±SD, median (range) or number (%).
IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity.
Points
Variables
-1 0 1 2 3
Gestation (weeks) ≥30 29 28 27 ≤26
Birth weight (g) >1,500 1,251- 1,001- 751- ≤750
1,500 1,250 1,000
5 min Apgar score ≥876 ≤5
FiO2 No ventilator* ≤0.25 0.26-0.35 >0.35
PIP/kg at 12 hr of age No ventilator* ≤10 10.1-15 15.1-20 >20
MAP/kg No ventilator* ≤3.0 3.1-4.5 4.6-6.0 >6.0
Modified OI
� No ventilator* ≤1.0 1.1-2.0 2.1-4.0 >4.0
Ventilatory modality No ventilator* CPAP IMV/SIMV A/C HFV
Table 2. Scoring table for prediction of neonatal chronic lung
disease
FiO2, fractional inspired oxygen; PIP/kg, peak inspiratory pressure divided
by birth weight; MAP/kg, mean airway pressure divided by birth weight;
CPAP, continuous positive airway pressure; IMV/SIMV, intermittent man-
datory ventilation/synchronized intermittent mandatory ventilation; A/C,
assisted and controlled mode of ventilation; OI, oxygenation index; HFV,
high-frequency ventilation. 
*No ventilatory therapy regardless of oxygen supplementation; 
� MAP is
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Fig. 1. Comparison of ROC curves of predictive models at day 4 (A), 7 (B) and 10 (C) of life for neonatal chronic lung disease [SMUMRV
(solid line) vs. Yoder model (dotted line)]. CLD is defined at 36 weeks of corrected age. Area under the curve: (A) SMUMRV, 0.90 (SEM,
0.07); Yoder, 0.92 (SEM, 0.06); p=0.73, (B) SMUMRV, 0.91 (SEM, 0.07); Yoder, 0.96 (SEM, 0.05); p=0.38, (C) SMUMRV, 0.94 (SEM, 0.05);
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gest that infants who require higher inspiratory pressure over
their birth weights to maintain PaO2 within normal ranges
have a higher tendency to develop CLD. We also found that
a significant portion of patients with CLD has been more
dependent upon highly advanced mechanical ventilatory tech-
niques (such as HFV or assist/control mode of ventilation) at
their early ages of life than those without CLD. Using the
modified respiratory variables, we attempted to predict the
development of neonatal CLD at an early age of life by means
of a simple and powerful clinical tool at the bedside.
Our scoring method for predicting neonatal CLD has some
advantages over current methods. Data can be obtained by
simple calculations at the bedside, not requiring complicat-
ed logistic equation. All the study subjects were admitted
to the same unit with same therapeutic strategy during the
study periods from data collection to cross-validation. Com-
bination of categorized variables makes it easier to compare
the severity of disease among patients who cannot be distin-
guished by the numerical disparities only. For example, we
can compare two theoretical patients. Patient A who requires
increased oxygen supplementation, from 0.3 to 0.6 of FiO2,
without artificial mechanical ventilation, and patient B who
is a newly set up on a mechanical ventilator with 0.3 of FiO2
and 14 mmHg of PIP. The respiratory condition of patient
B is not necessarily more severe than that of patient A, because
physiologic PIP will not be zero even if the patient has a severe
respiratory problem and it is hard to precisely estimate the
additional PIP needed to maintain the airway pressure. There-
fore, more than one factor will be helpful to evaluate the pro-
gression of disease or to compare the severity in respiratory
illness. Scoring method might help to meet the purpose.
Yoder et al. (12) firstly developed the respiratory failure
score for infants of <32 weeks’ gestation to predict neonatal
CLD at 36 weeks of CA. Although the Yoder model was a
simple scoring method for clinical application, the pressure
amplitude of HFV was compared with the PIP of conven-
tional ventilation, and the studies for validation were con-
ducted at different centers having different therapeutic strate-
gies. To overcome those drawbacks, we compared MAP of
HFV with that of conventional ventilation, and validated our
model prospectively at the same center in which it was devel-
oped from retrospective data. During the periods of our study,
there were no significant changes in the main clinical prac-
tices, except that fluid therapy was made more restrictively
since the last half of 1998.
Classification criteria of CLD for statistical analysis in our
study were different from other predictive models. In attempt-
ing to compare our results with those in other studies, we
found that each study used its own different analytical method
for predicting the development of neonatal CLD. For exam-
ple, Sinkin et al. (10) performed his study prior to surfactant
supplementation and HFV, obtained prospective data for
validation from different hospitals and recorded airway pres-
sure in infants without mechanical ventilatory support. Ryan
et al. (11) did not mention HFV and classified infants who
died after day 4 of life into the non-CLD group, whereas Yoder
et al. (12) classified infants who died after 7 days of life into
the CLD group. In our study, we excluded the patients who
died within 36 weeks of corrected age for the statistical analy-
sis. When we forcibly tried to adopt the respiratory failure
score (Yoder model) to our patients, we found that predictive
values in both models were still remained lower than 60%
even if we included our patients who died within 36 weeks
of corrected age into CLD group. Those results were much
different from Yoder’s one (12), which showed 75% of posi-
tive predictive values at 72 hr of life. It may partly be due to
discrepancy in prevalence of CLD between the two different
studies. The incidence of CLD in SMUMRV was much less
than in Yoder model (9.4% vs. 34%), and it could recipro-
cally affect the predictive values of our screening test. 
We also investigated the involvement of several antenatal
factors including maternal WBC counts and serum levels of
CRP and total immunoglobulin M, placental pathology and
WBC counts in the amniotic fluid. However, we were not
able to adopt these variables into the scoring method because
of incomplete medical records. We were able to obtain pla-
cental pathology data and amniocentesis data only in 61.3%
and 26.4% of total subject infants, respectively during period
I. Future inclusion of antenatal factors in the scoring method
would be expected to show a more clear relationship between
perinatal inflammation and the development of neonatal CLD.
Despite the limitations above, predictive values and the






SMUMRV >10 88.9 83.9 36.4 98.6
SMUMRV >11 88.9 89.7 47.2 98.7
SMUMRV >12 66.7 90.8 42.9 96.3
Yoder >0 88.9 78.2 26.7 98.6
Yoder >1 88.9 82.8 34.8 98.6
Yoder >2 77.8 87.4 39.0 97.4
Day 7
SMUMRV >10 88.9 86.2 40.0 98.7
SMUMRV >11 77.8 89.7 43.9 97.5
SMUMRV >12 66.7 90.8 42.9 96.3
Yoder >-2 100 78.2 32.2 100
Yoder >-1 88.9 82.8 56.4 98.9
Yoder >0 88.9 83.9 60.1 98.8
Day 10
SMUMRV >11 88.9 90.8 50.0 98.8
SMUMRV >12 77.8 95.4 63.6 97.6
SMUMRV >13 66.7 97.7 75 96.6
Yoder >0 88.9 82.8 34.8 98.6
Yoder >1 88.9 87.4 42.2 98.7
Yoder >2 66.7 95.4 60.0 96.5
Table 3. Comparison of predictive values for CLD at 36 weeks
of corrected age using the scoring method
PPV, positive predictive value; NPV, negative predictive value; CLD,
chronic lung disease.differences of ROC curves between the two models, based
on the area under the curves, did not achieve statistical sig-
nificance. Although these results were a little different from
what we have expected, it could still likely that our scoring
method using modified respiratory parameters might be a
reliable tool for the early prediction of the development of
neonatal CLD for infants born at <32 weeks gestation. More-
over, this method is simple enough to be easily utilized at the
bedside. Future research in a larger number of study subjects
should be considered to clarify the usefulness of our scoring
method for predicting neonatal CLD. 
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